Page 382 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux
P. 382

4. LES NORMOUPÉMIANTS                                       343

           CONOLLY P.J. "Relationship between tissus selectivity and lipophilicity for inhibitors
             of HMG-CoA reductase inhibitors” (1992) Chem Tracts Organic Chemistry, 15 (1),
             59-62.
           STUBB R J. et al. “Détermination of mevinolin and mevinolic acid in plasma and bile
             by reversed phase high-performance liquid chromatography" (1986) Journal of
             Chromatography, 383, 438-443.
           DUGGAN D.E. “The physiological disposition of lovastatin" (1989) Drug Metabolism
             and Disposition 17 (2), 166-173.
           PENTIKAINEN P.J. et al. “Comparative pharmacokinetics of lovastatin, simvastatin
             and pravastatin in humans" (1992) J Clin Pharmacol, 32, 136-140.
           SMITH G.B. et al. "Autooxydation of simvastatin" (1993) Tetrahedron 49 (21), 4447­
             4462.
           Pharmacologie
           Mévastatine
           A ENDO" Compactin (ML-236B) and related compounds as potential cholesterol-
             lowering agents that inhibit HMG-CoA reductase" (1985) J Med Chem, 28 (4), 401­
             405.
           Lovastatine
           "Expanded clinical évaluation of lovastatin (EXCEL) Study results :"
           I : BRADFORD R.H. étal. (1991) Arch Intern Med, 151, 43-49 ;
           Il : LATIES A.M. (1991) Am J Cardiol 67 (6), 447-453 ;
           III : BRADFORD R.H. et al. (1991 ) Am J Med 91 (Suppl 1 B) 185-245 ;
           IV : DUJOVNE C.A. étal. (1991) Am J Med 91 (suppl 1B) 255-305;
           V: BRADFORD R.H. étal. (1991) Am J Cardiol 66, 44B-55B.
           Simvastatine
           Zocor, simvastatine (1992) CD-ROM Vidal, OVP, éditions du Vidal, 11 rue Quentin
             Bauchard, 75008 Paris.
           Simvastatin (1989) Drugs Future, 14 (6), 595-597.
           Mévacor Prescribing information from Physician's Desk Reference (1992) by Medical
             Economies Data, a division of Medical Économies Company Inc.
           TODD P.A. et al. "Simvastatin : a review of its pharmacological properties and thera­
             peutic potential in hypercholesterolaemia" (1990) Drugs, 40 (4), 583-607.
           NICCOLI R. "Simvastatin for lowering cholestérol levels in non insulin-dependent dia­
             bètes mellitus and in primary hypercholesterolemia" (1992) Eur Therap Res, 51 (1),
             66-74.
           ZAMBON S. "Long-term treatment with simvastatin in hypercholesterolemic non-insu-
             lin dépendent diabetic patients” (1992) Eur Therap Res, 52 (2), 221-229.
           MARTINI S. “Efficacy and safety of simvastatin for the treatment of hypercholesterole­
             mia in patients with and without type II diabètes” (1992) Eur Therap Res, 52 (2),
             281-290.
           BOCCUZZI S.J. "Long term expérience with simvastatin" (1993) Drugs Invest, 5 (2),
             135-140.
           Pravastatine
           Eptastatin sodium (1987) Drugs Future 12 (5), 437-442.
   377   378   379   380   381   382   383   384   385   386   387